OneMedNet Corporation（納斯達克代碼：ONMD）於2026年7月24日提交8-K申報，宣佈2026年度股東大會將於2026年9月18日舉行，記錄日期定為2026年8月11日。由於今年會議日期較去年（2025年12月17…

false
 0001849380
 
 
 
 
 
 
 
 0001849380
 
 
 2026-07-24
 2026-07-24
 
 
 
 
 0001849380
 
 ONMD:CommonStock0.0001ParValuePerShareMember
 
 
 
 2026-07-24
 2026-07-24
 
 
 
 
 0001849380
 
 ONMD:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
 
 
 
 2026-07-24
 2026-07-24
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

WASHINGTON,
D.C. 20549

 

 

 

FORM
8-K

 

 

 

CURRENT
REPORT

Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date
of Report (Date of earliest event reported): July 24, 2026

 

 

 

ONEMEDNET
CORPORATION

(Exact
name of Registrant as Specified in Its Charter)

 

 

 

 
 Delaware
  
 001-40386
  
 86-2076743
 

 
 (State
 or Other Jurisdiction 

 of Incorporation)

  
 (Commission

 File Number)

  
 (IRS
Employer

 Identification No.)

 

 
 

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address
of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 800-918-7189

 

 

(Former
Name or Former Address, if Changed Since Last Report)

 

 

 

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

 

 
 ☐
 Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
  
  

 
 ☐
 Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities
registered pursuant to Section 12(b) of the Act:

 

 
 Title
 of each class

  
 Trading
 Symbol(s)

  
 Name
 of each exchange on which registered

 
 Common
 Stock, $0.0001 par value per share
  
 ONMD
  
 The
 Nasdaq Stock Market LLC

 
  
  
  
  
  

 
 Redeemable
 Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
  
 ONMDW
  
 The
 Nasdaq Stock Market LLC

 
 

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging
growth company ☒

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

  

 

 

Item
5.08 Shareholder Director Nominations.

 

To
the extent applicable, the information set forth below under Item 8.01 of this Current Report on Form 8-K is incorporated by reference
into this Item 5.08.

 

Item
8.01 Other Events.

 

The
Board of Directors of OneMedNet Corporation (the “Company”) has established September 18, 2026 as the date of the Company’s
2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). The record date for stockholders entitled to notice of and
to vote at the 2026 Annual Meeting will be August 11, 2026. Additional details regarding the 2026 Annual Meeting, including the matters
to be considered and voted upon at the 2026 Annual Meeting, will be set forth in the Company’s definitive proxy statement for the
2026 Annual Meeting to be filed with the Securities and Exchange Commission (the “SEC”).

 

Because
the 2026 Annual Meeting date has been changed by more than 30 calendar days from the anniversary date of the 2025 annual meeting held
on December 17, 2025 (the “2025 Annual Meeting”), pursuant to SEC Rule 14a-8 under the Securities Exchange Act of 1934, as
amended, and the Bylaws of the Company (the “Bylaws”), the deadlines for stockholder nominations and proposals for consideration
at the 2026 Annual Meeting set forth in the Company’s 2025 Annual Meeting proxy statement have been updated as set forth herein.

 

Proposals
by stockholders intended to be presented at the 2026 Annual Meeting must be received by the Secretary of the Company no later than August
5, 2026, to be eligible for inclusion in the Company’s proxy materials relating to the 2026 Annual Meeting. The Company
has determined that this date is a reasonable time before it expects to begin to print and send its proxy materials for the 2026 Annual
Meeting in accordance with Rule 14a-8(e). The Company will not be required to include in its proxy, notice of meeting or proxy statement
a stockholder proposal that is received after that date or that otherwise fails to meet the requirements for stockholder proposals established
by applicable SEC rules and the Bylaws. Any stockholder who intends to submit a proposal other than for inclusion in the Company’s
proxy materials for the 2026 Annual Meeting must deliver such proposal to the Secretary of the Company no later than August 5,
2026.

 

Any
proposals by stockholders intended to be presented at the 2026 Annual Meeting, and any notices of intent to solicit proxies for the 2026
Annual Meeting, should be mailed or delivered to OneMedNet Corporation, 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota 55344,
Attention: Secretary. Such proposals must also comply with all other requirements set forth in the Bylaws and other applicable laws.

 

As
set forth in the 2025 Annual Meeting proxy statement and as provided in the Bylaws, all stockholder nominations of candidates for election
as directors of the Company must be received by the Secretary of the Company no later than August 5, 2026. Additionally, pursuant
to SEC Rule 14a-19, a stockholder intending to engage in a director election contest with respect to the 2026 Annual Meeting must give
the Company notice of its intent to solicit proxies by providing the name(s) of the stockholder’s nominee(s) and certain other
information by August 5, 2026. All stockholder nominations must be made in writing and delivered or mailed to the Secretary of
the Company at the Company’s principal executive offices located at 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota
55344.

 

  

  

 

 

SIGNATURES

 

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

 

Dated:
July 24, 2026

 

 
  
 ONEMEDNET
 CORPORATION

 
  
  
  

 
  
 By: 
 /s/
 Aaron Green

 
  
  
 Aaron Green

 
  
  
 Chief Executive Officer